Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

CAG flays heavy expenditure by Mulayam govt on Safai airstrip
The Comptroller and Auditor General has termed as "unwise" the crores of rupees spent on the upgradation and extension of the airstrip in Safai, the native village of Mulayam Singh Yadav, during his tenure as Chief Minister of Uttar Pradesh. http://smallpersonalloans.org.uk

Centum Learning to set up campuses in 20 cities in India
Centum Learning, the education and training arm of Bharti group, is expanding its footprint in India by setting up skill development centres and mini-campuses for offering professional degrees to students. The company will cater to the entire spectrum of students from - low end to high end.

News of the day

Govt may divest only 10% stake in CIL
State-run Coal India (CIL) today said the government may divest only 10 per cent stake in the PSU in the next fiscal, against the desired 15 per cent, as regulatory provisions bars it from reserving some shares for employees.
Business Opportunities

Sun Pharma gets tentative FDA nod for generic Gleevec tablets

Sun Pharmaceutical Industries today said it has got tentative approval from the US drug regulator for generic Gleevec (imatinib meyslate tablets), used in the treatment of chronic myeloid leukaemia. - Glenmark Generics gets US FDA nod for Ciclopirox Olamine - Aurobindo gets USFDA nod for hypertension drug - Sun Pharma gains on HC order - HC stops Zydus drug sale on Sun petition - Aurobindo gets USFDA nod for Cefotaxime injection - India Eco Summit: Issues with USFDA to drag on, says Ranbaxy The US Food and Drug Administration (USFDA) has granted tentative approval for the company"s abbreviated new drug application (ANDA) for generic Gleevec, Sun Pharma said in a filing to the Bombay Stock Exchange (BSE). The tentatively approved drug (imatinib meyslate tablets) is therapeutically equivalent to Gleevec tablets of Novartis. The approval of imatinib mesylate tablets are in the strengths of 100 mg and 400 mg. The annual sales of these tablets are about 950 million dollars in the US. Shares of Sun Pharmaceutical were trading at Rs 1,451.90, down 1.74 per cent in the morning trade on the BSE.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009